AnaptysBio Inc
ANAB
NASDAQ
Biotechnology
$58.47
USD
+2.45 (+4.37%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $1.69B
Volume 330.8K
Price Target
$95.00 – $95.00
USD
The 1 analysts offering 1-year price forecasts have a max estimate of $95.00 and a min estimate of $95.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$95.00
+$19.4 vs prior
Implied Upside
+62.5%
+33.1% vs prior
Analyst Covering
1
-7 vs prior period
Consensus
Buy
Improved vs prior
Signal Quality
Consensus Freshness
11%
Many ratings are older - consensus may be less current
Analyst Agreement
High
Targets are closely clustered - analysts agree more than usual
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
1 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
1 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Joseph Pantginis | HC Wainwright & Co. | Buy | Resumed | 2 months ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
RXRX
Recursion Pharmaceuticals Inc
$3.16
▼ -4.5%
FBRX
Forte Biosciences Inc
$76.83
▼ -0.0%
DMRA
Damora Therapeutics Inc
$31.04
▲ +1.0%
TSHA
Taysha Gene Therapies Inc
$5.95
▼ -0.7%
SRPT
Sarepta Therapeutics Inc
$18.10
▼ -1.7%
NTLA
Intellia Therapeutics Inc
$11.91
▲ +0.7%
ZYME
Zymeworks Inc
$25.12
▼ -2.5%
SNDX
Syndax Pharmaceuticals Inc
$19.84
▲ +4.0%
TRAX
First Tracks Biotherapeutics Inc
$44.04
▲ +0.0%